IDEXX Laboratories Cash Flow from Investing Activities 2010-2024 | IDXX

IDEXX Laboratories cash flow from investing activities for the twelve months ending June 30, 2024 was $-0.467B, a 4.22% increase year-over-year.

  • IDEXX Laboratories annual cash flow from investing activities for 2023 was $-0.125B, a 35.88% decline from 2022.
  • IDEXX Laboratories annual cash flow from investing activities for 2022 was $-0.195B, a 33.32% decline from 2021.
  • IDEXX Laboratories annual cash flow from investing activities for 2021 was $-0.293B, a 167.85% increase from 2020.

IDEXX Laboratories Cash Flow from Investing Activities 2010-2024 | IDXX

IDEXX Laboratories cash flow from investing activities for the twelve months ending June 30, 2024 was $-0.467B, a 4.22% increase year-over-year.

  • IDEXX Laboratories annual cash flow from investing activities for 2023 was $-0.125B, a 35.88% decline from 2022.
  • IDEXX Laboratories annual cash flow from investing activities for 2022 was $-0.195B, a 33.32% decline from 2021.
  • IDEXX Laboratories annual cash flow from investing activities for 2021 was $-0.293B, a 167.85% increase from 2020.